发明名称 |
RITUXIMAB INDUCTION THERAPY FOLLOWED BY GLATIRAMER ACETATE THERAPY |
摘要 |
The present invention provides a method of treating a subject afflicted with a form of multiple sclerosis or presenting a clinically isolated syndrome comprising periodic administration of an amount of an anti-CD20 antibody at least twice to the subject followed by periodic administration of an amount of glatiramer acetate to the subject, wherein the amounts are effective to treat the subject. |
申请公布号 |
WO2014165280(A1) |
申请公布日期 |
2014.10.09 |
申请号 |
WO2014US25075 |
申请日期 |
2014.03.12 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD.;VOLLMER, TIMOTHY |
发明人 |
VOLLMER, TIMOTHY |
分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|